Your session is about to expire
What is Omniscan
GadodiamideThe Generic name of this drug
Treatment SummaryGadodiamide, also known as Omniscan, is a contrast agent used in MRI scans. It is injected into the bloodstream and helps to make blood vessels more visible during the scan.
Omniscanis the brand name
Omniscan Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Omniscan
Gadodiamide
2006
2
Approved as Treatment by the FDA
Gadodiamide, also known as Omniscan, is approved by the FDA for 3 uses including Stenosis and Magnetic Resonance Angiography .Stenosis
Magnetic Resonance Angiography
Constriction, Pathologic
Effectiveness
How Omniscan works in the bodyGadodiamide is used in MRI scans to help create images of the brain. It works by affecting the way protons react in a magnetic field. When placed in a magnetic field, gadodiamide speeds up the protons' reaction time and causes them to give off more energy. This makes it easier for MRIs to pick up the protons' signals, which are then used to create images of the brain. Gadodiamide does not cross the blood-brain barrier, so it only affects abnormal areas of the brain where the barrier has been disrupted. For example, it can be used to detect tumors, abscess
When to interrupt dosage
The recommended measure of Omniscan is contingent upon the diagnosed condition, including MRI Scan, Magnetic Resonance Angiography and Stenosis. The magnitude of dosage is subject to the delivery approach outlined in the table below.Condition
Dosage
Administration
Constriction, Pathologic
, 287.0 mg/mL
, Intravenous, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, Injection - Intravenous
abnormal vascularity
, 287.0 mg/mL
, Intravenous, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, Injection - Intravenous
Magnetic Resonance Angiography
, 287.0 mg/mL
, Intravenous, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, Injection - Intravenous
MRI
, 287.0 mg/mL
, Intravenous, Solution, Solution - Intravenous, Liquid, Liquid - Intravenous, Injection, Injection - Intravenous
Warnings
Omniscan ContraindicationsCondition
Risk Level
Notes
Disease
Do Not Combine
Kidney
Do Not Combine
Common Omniscan Drug Interactions
Drug Name
Risk Level
Description
Abacavir
Minor
Gadodiamide may decrease the excretion rate of Abacavir which could result in a higher serum level.
Acetaminophen
Minor
Gadodiamide may decrease the excretion rate of Acetaminophen which could result in a higher serum level.
Aclidinium
Minor
Gadodiamide may decrease the excretion rate of Aclidinium which could result in a higher serum level.
Acrivastine
Minor
Gadodiamide may decrease the excretion rate of Acrivastine which could result in a higher serum level.
Albutrepenonacog alfa
Minor
Gadodiamide may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.
Omniscan Novel Uses: Which Conditions Have a Clinical Trial Featuring Omniscan?
Eleven current investigations are assessing the potential of Omniscan to ameliorate Stenosis, aberrant vascularization and Magnetic Resonance Angiography.Condition
Clinical Trials
Trial Phases
Constriction, Pathologic
1 Actively Recruiting
Not Applicable
MRI
17 Actively Recruiting
Phase 2, Not Applicable, Phase 3
abnormal vascularity
0 Actively Recruiting
Magnetic Resonance Angiography
0 Actively Recruiting
Patient Q&A Section about omniscan
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Who makes Omniscan?
"Omniscan is a ultrasound imaging agent used to help visualize abnormalities in the body. It is manufactured by GE Healthcare."
Answered by AI
What gadolinium is used for?
"Gadolinium-based contrast agents are drugs that are injected into a vein to improve the quality of an MRI or MRA."
Answered by AI
What is Omniscan used for?
"OMNISCAN is a gadolinium-based contrast agent used in MRI to visualize lesions with abnormal vascularity in the brain, spine, and associated tissues."
Answered by AI
Is Omniscan still on the market?
"As of February 1, 2018, Omniscan and intravenous Magnevist are no longer authorized for use, and a product recall of any existing unexpired stock is underway."
Answered by AI
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.